跳至主要内容
临床试验/NL-OMON39839
NL-OMON39839已完成不适用

Treatment adherence in patients treated with telaprevir for a chronic hepatitis C genotype 1 infection: an observational study - treatment adherence telaprevir

Academisch Medisch Centrum0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age 18 to 70 years
  • - BMI 18-38 kg/m2
  • - Treatment-naïve for HCV, virological relapse or partial virological response (> 2log10 decline at week 12) after previous treatment with peg/RBV
  • - HCV genotype 1a or 1b
  • - Clinical and laboratory findings consistent with a clinical diagnosis of chronic hepatitis C
  • - Serum HCV RNA >10.000 IU/mL at baseline

排除标准

  • History or symptoms of decompensated liver disease: Child-Pugh Class B or C, including ascites, hepatic encephalopathy, esophageal variceal bleeding or other signs of hepatic insufficiency or portal hypertension ;Positive results on the following screening laboratory tests: urine or serum pregnancy test (for women of childbearing potential), hepatitis B surface antigen and human immunodeficiency virus (HIV) antibody.

研究者

相似试验

进行中(未招募)
1 期
Adherencia de los pacientes en el uso de Travalert® para la instilación de una combinación fija de travoprost 0.004% / timolol 0.5% comparado con un régimen concomitante de travoprost 0.004% y timolol 0.5%(Patients adherence using Travalert® to a fixed combination of travoprost 0.004% / timolol 0.5% compared to a concomitant regimen of travoprost 0.004% plus timolol 0.5%)Reducción de la presión intraocular en pacientes con glaucoma de angulo abierto o con hipertensión ocular, que no respondan a monoterapia de betabloqueantes o análogos de las prostaglandinas Intraocular pressure reduction in patients with open-angle glaucoma, or intraocular hypertension when they do not respond to betablockers or ophthalmic prostaglandin analog monotherapy.MedDRA version: 9.1Level: LLTClassification code 10030348Term: Open angle glaucomaMedDRA version: 9.1Level: LLTClassification code 10030043Term: Ocular hypertension
EUCTR2007-000515-29-ESAlcon Laboratories Inc.92
已完成
不适用
Treatment persistence and adherence in patients with Parkinson's disease in Japan: a retrospective observational study using health insurance claim databasesParkison&#39s disease
JPRN-UMIN000052869Eisai Co., Ltd.
招募中
不适用
Investigation of adherence to eyedrops in patients with glaucomaGlaucomaH40-H42
RBR-7r2r7nAllergan
已完成
不适用
Investigating the Effect of Adherence to Therapeutic Regimen program on the Quality of Life in Patients with Atrial FibrillatioPersistent atrial fibrillation
IRCT20190203042608N1Esfahan University of Medical Sciences50
招募中
不适用
Treatment adherence therapy in non-adherent patients with psychotic disorders; a randomised trial.1. Schizophrenia<br />2. psychosis<br />(NLD: schizofrenie, psychose).
NL-OMON26923Erasmus MC University, Rotterdam, THE NETHERLANDS120